Targeting the SARS-CoV-2 main protease using FDA-approved...

Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2–P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach

Achilonu, Ikechukwu, Iwuchukwu, Emmanuel Amarachi, Achilonu, Okechinyere Juliet, Fernandes, Manuel Antonio, Sayed, Yasien
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Journal:
Journal of Molecular Graphics and Modelling
DOI:
10.1016/j.jmgm.2020.107730
Date:
December, 2020
File:
PDF, 3.49 MB
2020
Conversion to is in progress
Conversion to is failed